Integra LifeSciences Holdings Strategic Asset Allocation Index
Integra LifeSciences Holdings strategic asset allocation index. Integra LifeSciences Holdings (IART) has a Strategic Asset Allocation Index of 18.9% as of June 2023. Strategic assets (PP&E of $317.57 Million plus long-term investments of $-) total $317.57 Million, measured against net assets of $1.68 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check tangible net worth ratio of Integra LifeSciences Holdings to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Integra LifeSciences Holdings (2000–2022)
Strategic asset allocation index of Integra LifeSciences Holdings from 2000 to 2022. This chart shows how Integra LifeSciences Holdings's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of June 2023, the index stands at 18.9%, representing strategic assets of $317.57 Million against net assets of $1.68 Billion USD.
Integra LifeSciences Holdings Strategic Asset Allocation Index by Year (2000–2022)
Integra LifeSciences Holdings strategic asset allocation index by year from 2000 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Integra LifeSciences Holdings from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see IART market cap overview.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 17.3% | $311.30 Million | $311.30 Million | $- | $1.80 Billion | ▼ -1.2 pp |
| 2021 | 18.5% | $311.70 Million | $311.70 Million | $- | $1.68 Billion | ▼ -0.5 pp |
| 2020 | 19.0% | $287.53 Million | $287.53 Million | $- | $1.51 Billion | ▼ -4.8 pp |
| 2019 | 23.8% | $337.40 Million | $337.40 Million | $- | $1.42 Billion | ▲ +1.6 pp |
| 2018 | 22.2% | $305.46 Million | $300.11 Million | $5.35 Million | $1.38 Billion | ▼ -6.0 pp |
| 2017 | 28.2% | $271.74 Million | $269.25 Million | $2.49 Million | $962.31 Million | ▲ +1.6 pp |
| 2016 | 26.7% | $224.00 Million | $222.37 Million | $1.63 Million | $839.67 Million | ▼ -0.6 pp |
| 2015 | 27.3% | $205.18 Million | $205.18 Million | $- | $751.44 Million | ▼ -2.5 pp |
| 2014 | 29.8% | $209.99 Million | $209.99 Million | $- | $704.32 Million | ▼ -0.1 pp |
| 2013 | 29.9% | $200.31 Million | $200.31 Million | $- | $670.18 Million | ▼ -4.5 pp |
| 2012 | 34.4% | $177.90 Million | $177.90 Million | $- | $517.77 Million | ▲ +7.7 pp |
| 2011 | 26.7% | $131.38 Million | $131.38 Million | $- | $492.64 Million | ▲ +6.8 pp |
| 2010 | 19.9% | $99.46 Million | $99.46 Million | $- | $499.96 Million | ▲ +1.1 pp |
| 2009 | 18.8% | $83.53 Million | $83.53 Million | $- | $444.88 Million | ▼ -1.3 pp |
| 2008 | 20.1% | $70.38 Million | $70.38 Million | $- | $350.21 Million | ▼ -3.6 pp |
| 2007 | 23.7% | $61.73 Million | $61.73 Million | $- | $260.43 Million | ▲ +9.3 pp |
| 2006 | 14.4% | $42.56 Million | $42.56 Million | $- | $296.16 Million | ▲ +4.9 pp |
| 2005 | 9.5% | $27.45 Million | $27.45 Million | $- | $289.82 Million | ▲ +1.2 pp |
| 2004 | 8.3% | $25.46 Million | $25.46 Million | $- | $307.82 Million | ▲ +0.8 pp |
| 2003 | 7.5% | $20.07 Million | $20.07 Million | $- | $268.53 Million | ▲ +0.8 pp |
| 2002 | 6.7% | $16.56 Million | $16.56 Million | $- | $247.60 Million | ▲ +1.0 pp |
| 2001 | 5.7% | $11.66 Million | $11.66 Million | $- | $204.06 Million | ▼ -15.9 pp |
| 2000 | 21.6% | $11.60 Million | $11.60 Million | $- | $53.78 Million | — |